Immunotherapy Drug Keytruda Halts ‘Untreatable’ Prostate Cancer In Some Men – Tech Times
Tech Times |
Immunotherapy Drug Keytruda Halts ‘Untreatable’ Prostate Cancer In Some Men
Tech Times Earlier trials on using immunotherapy in prostate cancer have been unsuccessful. The latest trial, results of which were presented this weekend at the American Society of Clinical Oncology Meeting in Chicago, examined the genetics of tumors and found … Immunotherapy could stop prostate cancer spreading, trial showsThe Guardian Immunotherapy could treat prostate cancerThe European Scientist ‘Untreatable’ prostate cancer halted in some men by new immunotherapy drug, trial findsThe Independent Forbes –BBC News –NHK WORLD all 52 news articles » |
|
ASCO18: Celgene makes its case as CAR–T rival in lymphoma
BioPharma Dive Celgene’s experimental cell therapy JCAR017, or liso-cel, could prove competitive in lymphoma with already on-market treatments from Gilead and Novartis, suggest updated clinical results presented Sunday at the annual meeting of the American Society of … |
CTV News |
Edmonton family holds swab event in Calgary to find stem cell donor
CTV News Back in January, Bille Nguyen was diagnosed with a rare type of blood cancer that specialists say could be helped through a special treatment using a stem cell donation. The problem is that because Nguyen is Asian, there aren’t enough donors in the … |
STAT |
ASCO in 30: Immunotherapy controversy & less is just as good
STAT Sharon covers science and discovery. sharon.begley@statnews.com 3. @sxbegle 4. Adam Feuerstein 5. Senior Writer, Biotech. Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. |
Pain News Network |
Taking Stem Cells to the Bank
Pain News Network There’s a lot of hope and hype surrounding stem cells – the latest being the idea of “banking” them — harvesting and storing your own stem cells for future use. A biotech start-up called Forever Labs maintains that young adults have healthier cells … |